Patients with suspected stroke require urgent evaluation in order to identify those who may be eligible for time-sensitive therapies. A focused and systematic approach to diagnosis improves the likelihood of identifying patients with probable ischemic stroke and minimizes the chances of exposing patients with alternate diagnoses to potentially harmful treatment. This chapter emphasizes the historical, examination, and neuroimaging findings useful in the rapid evaluation and diagnosis of patients with suspected ischemic stroke. Other entities that may present with strokelike symptoms will also be discussed.
Relationship Disclosure: Drs Barrett and Levine have nothing to disclose. Dr Johnston has received personal compensation for activities with AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Diffusion Pharmaceuticals LLC, NIH-National Institute of Neurological Disorders and Stroke, Ono Pharmaceutical Co., Ltd, Remedy Pharmaceuticals, and sanofi-aventis. Dr Johnston has received personal compensation in an editorial capacity from Up-to-Date and Neurology.
Unlabeled Use of Products/Investigational Use Disclosure: Drs Barrett and Levine have nothing to disclose. Dr Johnston discusses the unlabeled use of investigational therapies.